1-phenyl-5-mercaptotetrazole profile

1-phenyl-5-mercaptotetrazole: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	690730
CHEMBL ID	226652
CHEBI ID	79916
SCHEMBL ID	55213
MeSH ID	M0085538

Synonyms (77)

Synonym
nsc-44916
nsc44916
1-phenyltetrazole-5-thiol
5-mercapto-1-phenyltetrazol
1h-tetrazole-5-thiol, 1-phenyl-
5h-tetrazole-5-thione,2-dihydro-1-phenyl-
2-tetrazoline-5-thione, 1-phenyl-
phenylmercaptotetrazole
mercaptophenyltetrazole
5-mercapto-1-phenyltetrazole
nsc24018
1-phenyl-5-mercaptotetrazole
1-phenyl-5-mercapto-tetrazol
1-phenyl-5-tetrazolethione
wln: t5nnnnj ar& esh
1-phenyltetrazole-thiol
86-93-1
nsc-24018
1-phenyl-5-mercapto-1,3,4-tetrazole
1-phenyltetrazoline-5-thione
nsc-67819
nsc67819
5-mercapto-1-phenyl-1,2,3,4-tetrazole
1ph5shtetrazol
STK292840
1-phenyl-1h-tetrazole-5-thiol
1-phenyl-1h-tetrazole-5-thiol, 98%
5-mercapto-1-phenyl-1h-tetrazole
nsc 24018
einecs 201-710-5
1-phenyl-5-mercapto-1,2,3,4-tetrazole
5h-tetrazole-5-thione, 1,2-dihydro-1-phenyl-
AC-10636
inchi=1/c7h6n4s/c12-7-8-9-10-11(7)6-4-2-1-3-5-6/h1-5h,(h,8,10,12)
ggzhvnzhfycsev-uhfffaoysa-
1-phenyl-2h-tetrazole-5-thione
AKOS000294827
chebi:79916 ,
CHEMBL226652
P0640
1-phenyl-5-mercapto-1h-tetrazole
AKOS000119154
1-phenyl-1,2,3,4-tetraazole-5-thiol
1pi3bd9u68 ,
unii-1pi3bd9u68
F1324-0059
FT-0608251
FT-0608250
PS-4593
1-phenyl-1h-1,2,3,4-tetrazole-5-thiol
AM90368
SCHEMBL55213
5-mercapto-l-phenyl-1h-tetrazole
1-phenyl-5-thioxo-1,2,3,4-tetrazoline
1-phenyl-1h-tetrazol-5-thiol
DTXSID1052589
1-phenyltetrazolethiol
1,2,3,4-tetrazole-5-thiol, 1-phenyl-
W-104051
1-phenyl-5-thio-1h-tetrazole
STR04238
1-phenyl-2-tetrazoline-5-thione
1,2-dihydro-1-phenyl-5h-tetrazole-5-thione
1-phenyl-1,2-tetrazoline-5-thione
F0264-0010
1-phenyl-1h-tetrazole-5-thiol, for spectrophotometric det. of pd, for the determination of bi, >=97.0%
sr-01000389024
SR-01000389024-1
1-phenyl-1,4-dihydro-5h-tetrazole-5-thione
BCP05577
Q27149080
F15412
1-phenyltetrazole-5-thione
1-phenyl-1,2-dihydro-5h-tetrazole-5-thione
CS-0067555
EN300-17719
PD148028

Excerpt	Reference	Relevance
"Tetrazole, a bioisostere of the carboxylic acid group, can replace the carboxyl group in drugs to increase the lipophilicity, bioavailability and reduce side effects."	( Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Chang, L; Ding, C; Feng, LS; Gao, C; Wu, X; Xu, Z; Yan, XF; Zhao, F, 2019)	0.51

Class	Description
tetrazoles	An azole in which the five-membered heterocyclic aromatic skeleton contains four N atoms and one C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2	IC50 (µMol)	2.3600	0.0002	2.4585	9.9600	AID1640021
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (10)

Process	via Protein(s)	Taxonomy
3'-5'-RNA exonuclease activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoesters	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
protein guanylyltransferase activity	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Process	via Protein(s)	Taxonomy
double membrane vesicle viral factory outer membrane	Replicase polyprotein 1ab	Severe acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (30)

Assay ID	Title	Year	Journal	Article
AID287810	Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 21 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID461007	Selectivity index, ratio of CTD50 for MDCK cells to EC50 for Influenza A virus (A/Puerto Rico/8/34(H1N1))	2010	Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2	Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
AID287817	Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 14 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287835	Antiproliferative activity against mouse L929 cells after 72 hrs	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287836	Antiproliferative activity against human K562 cells after 72 hrs	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287811	Antimicrobial activity against Mycobacterium avium My 330/88 after 14 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1243324	Antimicrobial activity against Proteus mirabilis after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID1612601	Antibacterial activity against Mycobacterium kansasii CNCTC My 235/80	2019	European journal of medicinal chemistry, Feb-01, Volume: 163	Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
AID1243319	Antimicrobial activity against Staphylococcus aureus after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID287809	Antimicrobial activity against Mycobacterium tuberculosis My 331/88 after 14 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287816	Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 7 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287837	Cytotoxicity against human HeLa cells after 72 hrs	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1612603	Antibacterial activity against Mycobacterium kansasii isolate 6509/96	2019	European journal of medicinal chemistry, Feb-01, Volume: 163	Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
AID287814	Antimicrobial activity against Mycobacterium kansasii My 235/80 after 14 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1243320	Antimicrobial activity against Streptococcus spp. after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID287815	Antimicrobial activity against Mycobacterium kansasii My 235/80 after 21 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1243327	Antimicrobial activity against Staphylococcus aureus after 24 hrs by microbroth dilution assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID287818	Antimicrobial activity against Mycobacterium kansasii My 6509/96 after 21 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1243326	Antimicrobial activity against Escherichia coli after 24 hrs by microbroth dilution assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID461006	Antiviral activity against Influenza A virus (A/Puerto Rico/8/34(H1N1)) infected in MDCK cells assessed as virus yield after 48 hrs end-point dilution method	2010	Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2	Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
AID287812	Antimicrobial activity against Mycobacterium avium My 330/88 after 21 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID287813	Antimicrobial activity against Mycobacterium kansasii My 235/80 after 7 days	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
AID1243323	Antimicrobial activity against Klebsiella pneumoniae after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID1243321	Antimicrobial activity against Bacillus subtilis after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID1243325	Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID1612602	Antibacterial activity against Mycobacterium avium CNCTC My 330/88	2019	European journal of medicinal chemistry, Feb-01, Volume: 163	Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
AID461005	Cytotoxicity against MDCK cells after 48 hrs by MTT assay	2010	Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2	Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
AID1243322	Antimicrobial activity against Escherichia coli after 24 hrs by well-diffusion assay	2015	Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18	Synthesis, antibacterial and QSAR evaluation of 5-oxo and 5-thio derivatives of 1,4-disubstituted tetrazoles.
AID1612600	Antibacterial activity against Mycobacterium tuberculosis CNCTC My 331/88	2019	European journal of medicinal chemistry, Feb-01, Volume: 163	Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
AID1159607	Screen for inhibitors of RMI FANCM (MM2) intereaction	2016	Journal of biomolecular screening, Jul, Volume: 21, Issue:6	A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (10.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (10.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	9 (90.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
betaine glycine betaine : The amino acid betaine derived from glycine.	1.95	1	amino-acid betaine; glycine derivative	fundamental metabolite
catechol [no description available]	2.04	1	catechols	allelochemical; genotoxin; plant metabolite
hydroquinone [no description available]	2.04	1	benzenediol; hydroquinones	antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent
ciprofloxacin Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.. ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.	2.03	1	aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion	antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic
fluconazole Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.. fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.	2.03	1	conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug	environmental contaminant; P450 inhibitor; xenobiotic
isoniazid Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.. hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).	3.59	2	carbohydrazide	antitubercular agent; drug allergen
rimantadine Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.	2.05	1	alkylamine
acetonitrile acetonitrile: RN given refers to unlabeled cpd. acetonitrile : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by a methyl group.	2	1	aliphatic nitrile; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent
benzoxazoles 1,3-benzoxazole : A benzoxazole in which the benzene ring is fused to a 1,3-oxazole ring across positions 4 and 5.. benzoxazole : Compounds based on a fused 1,2- or 1,3-oxazole and benzene bicyclic ring skeleton.	1.95	1	1,3-benzoxazoles; mancude organic heterobicyclic parent
thiazoles [no description available]	1.95	1	1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
ethambutol Ethambutol: An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863). ethambutol : An ethylenediamine derivative that is ethane-1,2-diamine in which one hydrogen attached to each of the nitrogens is sutstituted by a 1-hydroxybutan-2-yl group (S,S-configuration). It is a bacteriostatic antimycobacterial drug, effective against Mycobacterium tuberculosis and some other mycobacteria. It is used (as the dihydrochloride salt) in combination with other antituberculous drugs in the treatment of pulmonary and extrapulmonary tuberculosis; resistant strains of M. tuberculosis are readily produced if ethambutol is used alone.	3.31	1	ethanolamines; ethylenediamine derivative	antitubercular agent; environmental contaminant; xenobiotic
2-methylthiazoline [no description available]	1.95	1	thiazoles
azides Azides: Organic or inorganic compounds that contain the -N3 group.. azide : Any nitrogen molecular entity containing the group -N3.	1.95	1	pseudohalide anion	mitochondrial respiratory-chain inhibitor
1h-tetrazole tetrazole : An azaarene that is a five-membered ring composed of 4 nitrogen and 1 carbon atom.. 2H-tetrazole : A tetrazole tautomer where the proton is located on the 2 position.	2.17	1	one-carbon compound; tetrazole
artemisinin (+)-artemisinin : A sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.	3.31	1	organic peroxide; sesquiterpene lactone	antimalarial; plant metabolite
artenimol [no description available]	3.31	1
amphotericin b Amphotericin B: Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.. amphotericin B : A macrolide antibiotic used to treat potentially life-threatening fungal infections.	2.03	1	antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic	antiamoebic agent; antiprotozoal drug; bacterial metabolite
silicon Silicon: A trace element that constitutes about 27.6% of the earth's crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight [28.084; 28.086].	2.17	1	carbon group element atom; metalloid atom; nonmetal atom
artesunate artesunic acid: RN given for (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,(2aR*))-isomer; succinic ester of artemether	3.31	1	artemisinin derivative; cyclic acetal; dicarboxylic acid monoester; hemisuccinate; semisynthetic derivative; sesquiterpenoid	antimalarial; antineoplastic agent; ferroptosis inducer
rifampin Rifampin: A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)	3.31	1	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor

Condition	Relationship Strength	Studies
Anemia, Fanconi [description not available]	2.13	1
Fanconi Anemia Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)	2.13	1
Anasarca [description not available]	1.97	1
Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.	1.97	1

1-phenyl-5-mercaptotetrazole

Description

Cross-References

Synonyms (77)

Research Excerpts

Bioavailability

Drug Classes (1)

Protein Targets (1)

Inhibition Measurements

Molecular Functions (10)

Ceullar Components (1)

Bioassays (30)

Research

Studies (10)

Market Indicators

Research Demand Index: 20.03

Study Types

1-phenyl-5-mercaptotetrazole

Description

Cross-References

Synonyms (77)

Research Excerpts

Bioavailability

Drug Classes (1)

Protein Targets (1)

Inhibition Measurements

Molecular Functions (10)

Ceullar Components (1)

Bioassays (30)

Research

Studies (10)

Market Indicators

Research Demand Index: 20.03

Study Types

Related Drugs (20)

Related Conditions (4)